i haven't posted in this thread in a while because i realized that lame dude who bought this will just do anything it takes to get famous. since then all his antics are easily explainable and kinda boring.
EMCEE DARTH MALEK wrote:i haven't posted in this thread in a while because i realized that lame dude who bought this will just do anything it takes to get famous. since then all his antics are easily explainable and kinda boring.
bro he was a douche waayyy before he bought the album trust me he didn't just become a douche after he bought the album.
I'd be lying if I said I didn't think Ghost (and Priest) are hard up for money with this vap shit they're doing. IDK if its vap but clearly they have some biz now that isn't music related. Not hating on their hustle but all Martin has to do is call Ghost and be like, I'm sorry, here is some $ and let's work together and it would happen. This is all soap opera shit but I'm not really feeling this direction with the god Ghost.
I briefly flashed an ill conspiracy theory that Shkirelz is trying to break into the legal weed business and actually has shares in the Wugoo thing and this is all a big viral marketing push for some line of wu-branded weed/paraphernalia and all parties are in on the joke together
I don't know if they're caking like Betty Crocker off the shit, but it's already at a bunch of storefront dispensaries and on the menu of several delivery services throughout the Bay Area.
U.S. prosecutors consider more charges against ex-CEO Shkreli
Former drug executive Martin Shkreli, who last year became a lightning rod for outrage over soaring prescription drug prices, may face additional U.S. charges of securities fraud, a federal prosecutor said on Tuesday.
More charges related to Shkreli's involvement with biopharmaceutical company Retrophin Inc could be filed within a month, Assistant U.S. Attorney Winston Paes said at a hearing in federal court in Brooklyn, New York.
Shkreli, 33, sparked outrage among patients, medical societies and U.S. lawmakers after another company he ran, Turing Pharmaceuticals, raised the price of the drug Daraprim by more than 5,000 percent to $750 a pill.
In December, U.S. authorities arrested him on fraud charges unrelated to the pricing of Daraprim, saying he ran his investment funds and companies almost like a Ponzi scheme. He stepped down from Turing and was fired from KaloBios Pharmaceuticals Inc.
Shkreli has pleaded not guilty, and his lawyer Benjamin Brafman told reporters after Tuesday's court hearing that he did not believe additional charges would change the case. After the hearing and on Twitter, Shkreli said he did not commit a crime and he agreed with a Twitter user who said Shkreli would not get a fair trial.
Lawyers at the hearing discussed possible trial dates late this year or in early 2017 for Shkreli and for Evan Greebel, a lawyer charged in the same case. Greebel has pleaded not guilty.